Position in PFE
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$367,797
-$65,561 QoQ
Shares Held
15,274
-1.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,968
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Family Manage LLC holds $23,478,755 across 9 Drug Manufacturers - General names. PFE ranks #8 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
43,515 | $11,051,504 | |
| 2 | MRK |
Merck & Co., Inc.
|
34,626 | $4,449,441 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
29,547 | $3,732,967 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
20,516 | $1,182,131 | |
| 5 | LLY |
ELI LILLY & Co
|
890 | $1,067,492 | |
| 6 | ABBV |
AbbVie Inc.
|
4,143 | $1,042,544 | |
| 7 | AMGN |
Amgen Inc
|
1,027 | $371,897 | |
| 8 | PFE |
Pfizer Inc
This page
|
15,274 | $367,797 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $367,797 | 15,274 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $433,358 | 15,433 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $353,629 | 14,202 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $3,420,154 | 134,229 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,206,903 | 132,298 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $408,455 | 16,119 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $418,271 | 15,766 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $492,906 | 17,032 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $454,870 | 16,257 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $627,843 | 22,625 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $676,392 | 23,494 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,602,726 | 108,614 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $4,089,526 | 111,492 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,535,654 | 111,168 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,848,584 | 114,141 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,111,736 | 116,813 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,550,092 | 29,565 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $1,623,144 | 31,353 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,834,683 | 31,070 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,370,341 | 31,861 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,461,059 | 37,310 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,151,679 | 31,788 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,055,453 | 28,673 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $896,103 | 24,417 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $917,203 | 28,049 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $771,412 | 23,634 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||